PIEZO2 and breast cancer: All these results together provide plenitudinous evidence that PIEZO2, downregulated by five oncogenic miRNAs (miR-130b-3p, miR-196a-3p, miR-301a-3p, miR-421 and miR-454-3p), might promote survival and progression of breast cancer by decreasing expression of CDON.